Logo image
Sign in
A Reappraisal of the Risks and Benefits of Treating to Target with Cholesterol Lowering Drugs
Journal article   Peer reviewed

A Reappraisal of the Risks and Benefits of Treating to Target with Cholesterol Lowering Drugs

Venkata M. Alla, Vrinda Agrawal, Andrew DeNazareth, Syed M. Mohiuddin, Sudha Ravilla, Marc S. Rendell and Andrew G. De Nazareth
Drugs, Vol.73(10), pp.1025-1054
2013
PMID: 23754124

Metrics

4 Record Views

Details